Institutional investors control 12.01% of the outstanding shares in BGMD. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2015, these large investors purchased a net $581.2 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRENTISS SMITH & CO., INC. Sold 1.3 Thousand shares of BG Medicine Inc
UNITED BANK, INC. (PARKERSBURG, ... Sold 2.5 Thousand shares of BG Medicine Inc
WELCH & FORBES LLC Sold 2.6 Thousand shares of BG Medicine Inc